Search Within

Biostatistics Service

  1. "Hematologic Malignancies Research"
Formats
  1. Meeting Abstract (180)
  2. Journal Article (139)
  3. Research Letter (7)
  4. Correspondence (4)
  5. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (331)
  2. Epidemiology and Biostatistics (331)
  3. Hematologic Malignancies Research (331)
  4. Department of Medicine (325)
  5. Hematologic Malignancies, Division of (313)
  6. Bone Marrow Transplant (208)

More Groups

People
  1. Sergio Giralt (165)
  2. Alexander Lesokhin (155)
  3. Hani Hassoun (136)
  4. Heather Landau (129)
  5. David Chung (123)
  6. Sham Mailankody (117)

More People

Years
  1. 2025 (13)
  2. 2024 (25)
  3. 2023 (36)
  4. 2022 (29)
  5. 2021 (26)
  6. 2020 (24)

More Years

Publications
  1. Blood (115)
  2. Clinical Lymphoma, Myeloma and Leukemia (27)
  3. Biology of Blood and Marrow Transplantation (25)
  4. Journal of Clinical Oncology (21)
  5. Blood Advances (12)
  6. Bone Marrow Transplantation (12)

More Publications

Publishers
  1. American Society of Hematology (127)
  2. Elsevier Inc. (54)
  3. Nature Publishing Group (53)
  4. American Society of Clinical Oncology (22)
  5. American Association for Cancer Research (19)
  6. Taylor & Francis Group (8)

More Publishers

Results (331)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Longitudinal in vivo tracking of novel human anti-IL13Rα2-scFv-derived CAR-T cells using radiohapten capture
    Meeting Abstract

    Mirzaei, H. R.; Lovibond, S.; Gajecki, L.; Qureshy, S.; Kumpf, M.; Jeanjean, P.; Lee, S. G.; Cai, W.; Miranda, I.; Mauguen, A.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma
    Journal Article

    Adegbite, B.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: A real-world experience
    Journal Article

    Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; more...
    Blood Neoplasia (2025)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma
    Correspondence

    Sebastian, T.; Rajeeve, S.; Farzana, T.; Firestone, R.; Jurgens, E.; Miller, K.; Costa, B.; Lesokhin, A.; Tan, C.; Shah, G.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Results from first-in-human phase I study of a novel CD19-1XX chimeric antigen receptor with calibrated signaling in Large B-cell lymphoma
    Journal Article

    Park, J. H.; Palomba, M. L.; Perica, K.; Devlin, S. M.; Shah, G.; Dahi, P. B.; Lin, R. J.; Salles, G.; Scordo, M.; Nath, K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Kitlo hematopoietic stem cells exhibit distinct lymphoid-primed chromatin landscapes that enhance thymic reconstitution
    Journal Article

    Elias, H. K.; Mitra, S.; da Silva, M. B.; Rajagopalan, A.; Gipson, B.; Lee, N.; Kousa, A. I.; Ali, M. A. E.; Grassmann, S.; Raghuraman, R.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies
    Journal Article

    Einarsdottir, S.; Lobaugh, S.; Luan, D.; Gomez-Llobell, M.; Subramanian, P.; Devlin, S.; Chung, D.; Dahi, P. B.; Falchi, L.; Giralt, S.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing
    Research Letter

    Tan, C. R.; Wang, A.; Nemirovsky, D.; Derkach, A.; Shekarkhand, T.; Hamadeh, I.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • HIV immune evasin Nef enhances allogeneic CAR T cell potency
    Journal Article

    Perica, K.; Kotchetkov, I. S.; Mansilla-Soto, J.; Ehrich, F.; Herrera, K.; Shi, Y.; Dobrin, A.; Gönen, M.; Sadelain, M.
    Nature (2025)

    Fulltext@MSK | Save
  • Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies
    Journal Article

    Shahid, S.; Prockop, S. E.; Flynn, G. C.; Mauguen, A.; White, C. O.; Bieler, J.; McAvoy, D.; Hosszu, K.; Cancio, M. I.; Jakubowski, A. A.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save